GIL
Gildan Activewear Inc.
GIL trails on the overall score without a compensating advantage in the available component scores.
NIO
NIO Inc.
NIO has the edge over GIL overall, supported by stronger valuation and stronger modeled upside.
GIL Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Weak |
GIL's revenue, profitability and cash flow are currently healthy, but its balance sheet is weak.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
GIL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.2x | $34.83 | — |
| Cheap | 11x | $5.67 | -84% |
| Fair | 17x | $9.22 | -74% |
| Expensive | 24x | $12.73 | -63% |
| Current | 65x | $34.83 | — |
Historical ranges are pointers, not guarantees.
GIL's PE is in its expensive range at 65x. On analysts' estimates for next year's earnings, today's price would be 9.2x, in its cheap range.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
GIL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Decline | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect GIL's earnings to decline, with its revenue and profitability holding steady.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
NIO has the edge over GIL on the outlook, with more favorable earnings and revenue expectations.
GIL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.78 | +599% |
| Q3 2025 | $3.13 | +24% |
| Q3 2024 | $2.52 | -3.8% |
| Q2 2024 | $2.43 | -11% |
| Q1 2024 | $2.96 | +10% |
| Q4 2023 | $3.04 | +4.1% |
| Q3 2023 | $2.62 | -22% |
| Q2 2023 | $2.73 | -21% |
| Q1 2023 | $2.69 | -20% |
GIL has the stronger earnings trend. Trailing diluted EPS is down 79% for GIL versus NIO down 117%.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
GIL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.5B | +68% |
| Q1 2026 | $1.2B | +64% |
| Q4 2025 | $1.1B | +33% |
| Q3 2025 | $910.6M | +2.2% |
| Q2 2025 | $918.5M | +6.5% |
| Q1 2025 | $711.7M | +2.3% |
| Q4 2024 | $821.5M | +5% |
| Q3 2024 | $891.1M | +2.4% |
GIL's revenue has grown year over year for nine quarters in a row: $1.5B last quarter, up 68% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 17% | -4.9 points |
| Q1 2026 | 5.1% | -13 points |
| Q4 2025 | 17% | -4.6 points |
| Q3 2025 | 21% | N/A |
| Q2 2025 | 22% | +0.1 points |
| Q1 2025 | 18% | +2.2 points |
| Q4 2024 | 22% | +6.7 points |
| Q3 2024 | 22% | +3.8 points |
GIL has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO's revenue has grown year over year for seven quarters in a row: $4.8B last quarter, up 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
GIL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $316.5M | +93% |
| Q1 2026 | -$309.9M | -$145.4M |
| Q4 2025 | $280.6M | +65% |
| Q3 2025 | $203.1M | +35% |
| Q2 2025 | $163.7M | +58% |
| Q1 2025 | -$164.5M | -$93.1M |
| Q4 2024 | $169.9M | -16% |
| Q3 2024 | $150.5M | -43% |
GIL generated $490M in free cash flow over the past year, up 53% from the year before.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
GIL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 6.4x | High |
| Q1 2026 | 7.5x | High |
| Q4 2025 | 6.1x | High |
| Q3 2025 | 2.2x | Moderate |
| Q3 2024 | 2.1x | Moderate |
| Q2 2024 | 1.8x | Healthy |
| Q1 2024 | 1.6x | Healthy |
| Q4 2023 | 1.4x | Healthy |
GIL's net debt is about 6.4 years of its operating earnings (EBITDA), up from 2.1 years a year ago.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GIL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.2 | Oversold |
| Stochastic | 9.3 | Oversold |
GIL's weekly RSI is 26 (oversold) and its Stochastic is 9 (oversold).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
GIL PE vs Consumer Cyclical Sector
| Metric | GIL | Sector median | Relative |
|---|---|---|---|
| PE | 65x | 18x | 258% above |
| PE % | 96 | 47 | 49 pts above |
GIL is trading at 65x earnings, a 258% premium to the Consumer Cyclical sector's median of 18x.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
GIL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.3 | 11% below |
| 20 week MA | $47.5 | 27% below |
| 50 week MA | $55.7 | 37% below |
| 100 week MA | $53.4 | 35% below |
| 200 week MA | $44.5 | 22% below |
GIL is in a downtrend: it's below all five of its weekly moving averages, and 22% below its 200-week average.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
GIL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.6 | $28.2 | -4.5% |
| 2021 | $28.2 | $40.8 | +44% |
| 2022 | $40.8 | $27.1 | -34% |
| 2023 | $27.1 | $33.1 | +22% |
| 2024 | $33.1 | $46.9 | +42% |
| 2025 | $46.9 | $63.6 | +36% |
| 2026 YTD | $63.6 | $34.8 | -45% |
GIL is down 45% so far in 2026, after finishing higher in four of the previous six years.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO has the edge over GIL on returns for 2026, with the stronger performance.